Showing all results Page 5 of 16

How Indonesia’s healthcare transformation will impact its IVD market

March 9th, 2023

Indonesia’s in-vitro diagnostics (IVD) market will recover and grow in the 2023 to 2026 period, reversing the deep market contraction experienced in the pandemic years. The expansion of Jaminan Kesehatan Nasional (JKN) – the country’s universal healthcare system is set to increase healthcare spending and access to diagnostic tests over the coming years, driving growth in the IVD market. 

  • Clearstate Insights
  • Centralised Diagnostics (CEDx)
  • In-vitro diagnostics
  • Molecular Diagnostics (MDx)
  • Point-of-care testing (POCT)
  • Asia
  • Centralised Diagnostics (CEDx)
  • IVD Gateway
  • Molecular Diagnostics (MDx)
  • Point-of-care testing (POCT)

Orthopaedic and spinal surgery devices hub

With an ageing population and the rising prevalence of orthopaedic and spinal conditions, technologies and devices are being developed to treat patients more efficiently and less invasively using minimally invasive surgery (MIS) techniques and robotics.

  • Page
  • Orthopaedic & Spine Surgery
  • Surgical device
  • Orthopaedic & Spine Surgery
  • Surgical Gateway

How inflation will impact Brazil’s IVD market

February 21st, 2023

Brazil’s in-vitro diagnostics (IVD) market will recover in the 2023 to 2026 period and grow slightly at an average of under 1% per year, reversing the market contraction experienced in the pandemic years. The market focus will expand beyond routine tests and increasingly drive uptake of preventive tests, such as next-generation sequencing (NGS) tests for cancer and infectious diseases.

  • Clearstate Insights
  • Centralised Diagnostics (CEDx)
  • In-vitro diagnostics
  • Molecular Diagnostics (MDx)
  • Point-of-care testing (POCT)
  • Uncategorised
  • Americas

Testing times: opportunities for IVD companies in 2023

February 13th, 2023

Growth opportunities from covid-19 have helped fuel rapid expansion for both established and emerging IVD companies. IVD companies have tapped into the increased global demand to drive growth, with some companies doubling their revenues during the pandemic years. 

  • Campaign
  • Centralised Diagnostics (CEDx)
  • In-vitro diagnostics
  • Point-of-care testing (POCT)
  • Tissue Diagnostics (TDx)
  • Americas
  • Asia
  • Europe
  • Global
  • Middle East & Africa

APAC IVD market to shrink by 2026 as demand for covid-19 testing cools further

February 9th, 2023

The Asia-Pacific (APAC) in-vitro diagnostics (IVD) market will continue to see key trends in hospital and patient care, government policies which will drive up overall diagnosis needs, and fuel fast growth for certain market segments. Find out more in our APAC IVD market update

  • Clearstate Insights
  • In-vitro diagnostics
  • Asia
  • IVD Gateway

Infectious Diseases Trend Monitor: India

The Indian government is increasing its investment on infectious disease surveillance and research to strengthen the country’s response to emerging infectious diseases.

  • Solutions
  • In-vitro diagnostics
  • Infectious Diseases Testing Monitor
  • Asia
  • Infectious Diseases Testing Monitor
  • IVD Gateway

Drive decision-making with IVD Size & Share Plus

February 6th, 2023

One of the largest IVD multinational companies plans to launch a new clinical chemistry assay in markets worldwide. To shore up their go-to-market strategy, the company needed to ensure that marketing will be tailored to achieve maximum impact in each market.

  • Case study
  • In-vitro diagnostics
  • Global
  • Centralised Diagnostics (CEDx)
  • IVD Gateway
  • Size and Share Plus

LATAM IVD market: fastest-growing emerging market region from 2021-2026

February 2nd, 2023

The Latin America (LATAM) in-vitro diagnostics (IVD) market is expected to recover in 2024 after government measures to mitigate the worsening socioeconomic crisis amidst the Covid-19 pandemic. Find out more in our LATAM IVD market update

  • Clearstate Insights
  • In-vitro diagnostics
  • Americas
  • IVD Gateway

Minimally invasive and endoscopic spine surgery in Asia Pacific

February 2nd, 2023

Surgical treatment of spine conditions is evolving from traditional open surgery to Minimally Invasive Surgery (MIS) and Endoscopic Spine Surgery (ESS). In the Asia-Pacific region (APAC), the demand and delivery of these less intrusive procedures is accelerating.

  • Campaign
  • Minimally invasive surgery
  • Surgical device
  • Asia

Infectious Diseases Trend Monitor: China

China’s government is building up the country’s in vitro diagnostics (IVD) testing capacity to strengthen the country’s response to infectious diseases. The government is expected to invest more than Rmb 15.6bn in 2023 on infectious diseases prevention and control, targeting diseases including HIV, tuberculosis and other severe infectious diseases such as covid-19.

  • Solutions
  • In-vitro diagnostics
  • Infectious Diseases Testing Monitor
  • Asia
  • Infectious Diseases Testing Monitor
  • IVD Gateway

Andrew Salomone Viteritti

Andrew leads The Economist Intelligence Unit’s analysis on international commerce and regulations. He manages The EIU’s Country Commerce team, which produces comprehensive evaluations on the commercial regulatory environment across 56 major economies worldwide. He also serves as a senior member of The EIU’s Global Forecasting and broader Editorial operations. Andrew’s research focuses on key regulatory issues involving international trade, investment, competition, labour, migration and development, among other policy areas. He has served as an advisor and consultant on a number of policy projects at The EIU and other leading institutions. He frequently presents to various audiences, including policymakers and universities.

  • Person
  • Americas
  • Europe
  • Global

Asia-Pacific infectious disease diagnostics market trends

January 27th, 2023

In Asia-Pacific (APAC), many countries continue to build up in vitro diagnostics (IVD) testing capacity to strengthen the country’s response to infectious diseases. Clearstate expects infectious disease testing to grow.

  • Clearstate Insights
  • In-vitro diagnostics
  • Infectious Diseases Testing Monitor
  • Uncategorised
  • Asia
  • Infectious Diseases Testing Monitor
  • IVD Gateway